Pure Global AI
NCT06291922Not yet recruiting

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

University of PennsylvaniaClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Heart Failure
Drug/Device/Intervention
Exercise Intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Pennsylvania
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Jun 01, 2028
Enrollment
80 participants
Primary outcome

Effects of exercise intervention on physical activity and capacity (step count),Effects of exercise intervention on physical activity and capacity (distance)

Summary

The goal of this clinical trial is to evaluate the effects of a home-based exercise program
 using mobile technology on physical activity and capacity, frailty and muscle mass, and
 quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device
 (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care
 on physical activity and capacity, frailty and muscle mass, and quality of life.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06291922
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06291922 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.